Particle Coating In Two-Phase Microfluidic Co-Flows

两相微流体协流中的颗粒涂层

• 批准号: 435514-2013
• 负责人: Tsai, Scott
• 金额: $ 1.82万
• 依托单位: Ryerson University
• 依托单位国家: 加拿大
• 项目类别: Discovery Grants Program - Individual
• 财政年份: 2018
• 资助国家: 加拿大
• 起止时间: 2018-01-01 至 2019-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=667200
• 关键词: Particle; Coating; Two; Phase; Microfluidic

Cell transplantation therapies have shown great promise in treating diseases such as type I diabetes. However, the patients in all of the successful clinical treatments so far have been required to use immunosuppressive drugs. These drugs are often harmful to organs such as kidneys. Yet, without immunosuppression, the transplanted cells may be quickly destroyed by the patient's immune system.****Our laboratory is pursuing a new particle coating technology that will enable cell transplantation treatments without immunosuppression. We are developing the capability to coat individual particles, such as the cells being used in the treatment of type I diabetes, with a bio-compatible polymer membrane that protects the cells from the immune system and facilitates the transport of nutrients across the membrane.****We use a microfluidics platform--a system of microchannels where viscosity and surface tension dominate the physics of fluid flow--to develop our technology, and leverage our expertise in fluid mechanics and electromagnetism to control the coating process. Our approach includes both experimental observation of the coated single cells and mathematical modeling of the coating flow.****Most of all, we expect that our coating technology will greatly improve the viability of transplanted cells, which can positively impact the Canadian health care and biotechnology industries. We also anticipate significant interest from the global fluid mechanics community in our coating flow studies. Finally, through participation in this research program, our highly qualified personnel (HQP) will develop interdisciplinary skills in fields as diverse as engineering, medicine, and mathematics. These HQP will populate Canadian industry and apply our microscale coating technique to solve a variety of problems. **************

细胞移植疗法在治疗I型糖尿病等疾病方面显示出巨大的前景。然而，迄今为止所有成功的临床治疗都要求患者使用免疫抑制药物。这些药物通常对肾脏等器官有害。然而，如果没有免疫抑制，移植的细胞可能会很快被患者的免疫系统破坏。我们的实验室正在研究一种新的颗粒涂层技术，该技术将使细胞移植治疗无需免疫抑制。我们正在开发涂覆单个颗粒的能力，例如用于治疗I型糖尿病的细胞，具有生物相容性聚合物膜，可保护细胞免受免疫系统的影响，并促进营养物质穿过膜的运输。我们使用微流体平台-一种微通道系统，其中粘度和表面张力主导流体流动的物理特性-来开发我们的技术，并利用我们在流体力学和电磁学方面的专业知识来控制涂层过程。我们的方法包括对涂覆的单细胞的实验观察和对涂覆流的数学建模。最重要的是，我们希望我们的涂层技术将大大提高移植细胞的生存能力，这将对加拿大的医疗保健和生物技术产业产生积极影响。我们还预计全球流体力学界对我们的涂层流动研究会产生浓厚的兴趣。最后，通过参与这项研究计划，我们的高素质人员（HQP）将在工程，医学和数学等不同领域发展跨学科技能。这些HQP将填充加拿大工业，并应用我们的微型涂层技术来解决各种问题。**************